Review





Similar Products

92
Bethyl arid1a baf250 blr279l
Arid1a Baf250 Blr279l, supplied by Bethyl, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/arid1a+antibody/pmc13000123-269-71-74?v=Bethyl
Average 92 stars, based on 1 article reviews
arid1a baf250 blr279l - by Bioz Stars, 2026-08
92/100 stars
  Buy from Supplier

94
Santa Cruz Biotechnology arid1a
Arid1a, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/arid1a+antibody/pm41800254-90-9-10?v=Santa+Cruz+Biotechnology
Average 94 stars, based on 1 article reviews
arid1a - by Bioz Stars, 2026-08
94/100 stars
  Buy from Supplier

94
Santa Cruz Biotechnology anti arid1a
Anti Arid1a, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/arid1a+antibody/pm41800254-104-17-20?v=Santa+Cruz+Biotechnology
Average 94 stars, based on 1 article reviews
anti arid1a - by Bioz Stars, 2026-08
94/100 stars
  Buy from Supplier

86
Cell Signaling Technology Inc antibodies against arid1a
miR-663a is induced in esophageal cancer cells upon <t>ARID1A</t> depletion. (A) Bioinformatics analysis showed 14 differentially expressed miRs between esophageal cancer and adjacent normal tissues based on GEO datasets ( GSE157805 and GSE145198 ). (B) The protein expression of ARID1A in esophageal cancer cells transfected with shCtrl or ARID1A-targeting shRNAs was measured by Western blot analysis. GAPDH was used as the loading control. (C) Measurement of miR-663a levels in esophageal cancer cells transfected with indicated shRNAs. ***, P<0.001 vs . shCtrl. (D) The expression level of miR-663a in 50 pairs of esophageal cancer and adjacent normal tissues measured by quantitative real-time PCR analysis. (E) The correlation between the miR-663a and ARID1A mRNA expression levels in the 50 cases of esophageal cancer tissues. (F) Overall survival analysis in esophageal cancer patients according to the miR-663a expression level using the data from Kaplan-Meier plotter. Data in parentheses are 95% confidence interval. GEO, Gene Expression Omnibus; HR, hazard ratio; miR, microRNA; PCR, polymerase chain reaction; shCtrl, control shRNA; shRNA, short hairpin RNA.
Antibodies Against Arid1a, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/arid1a+antibody/pmc13067029-56-13-17?v=Cell+Signaling+Technology+Inc
Average 86 stars, based on 1 article reviews
antibodies against arid1a - by Bioz Stars, 2026-08
86/100 stars
  Buy from Supplier

86
Synthego Inc experimental models a375 synthego a375 arid1a ko synthego recombinant dna antibodies anti egfr alexa 488 biolegend
miR-663a is induced in esophageal cancer cells upon <t>ARID1A</t> depletion. (A) Bioinformatics analysis showed 14 differentially expressed miRs between esophageal cancer and adjacent normal tissues based on GEO datasets ( GSE157805 and GSE145198 ). (B) The protein expression of ARID1A in esophageal cancer cells transfected with shCtrl or ARID1A-targeting shRNAs was measured by Western blot analysis. GAPDH was used as the loading control. (C) Measurement of miR-663a levels in esophageal cancer cells transfected with indicated shRNAs. ***, P<0.001 vs . shCtrl. (D) The expression level of miR-663a in 50 pairs of esophageal cancer and adjacent normal tissues measured by quantitative real-time PCR analysis. (E) The correlation between the miR-663a and ARID1A mRNA expression levels in the 50 cases of esophageal cancer tissues. (F) Overall survival analysis in esophageal cancer patients according to the miR-663a expression level using the data from Kaplan-Meier plotter. Data in parentheses are 95% confidence interval. GEO, Gene Expression Omnibus; HR, hazard ratio; miR, microRNA; PCR, polymerase chain reaction; shCtrl, control shRNA; shRNA, short hairpin RNA.
Experimental Models A375 Synthego A375 Arid1a Ko Synthego Recombinant Dna Antibodies Anti Egfr Alexa 488 Biolegend, supplied by Synthego Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/arid1a+antibody/pm41708984-209-12-15?v=Synthego+Inc
Average 86 stars, based on 1 article reviews
experimental models a375 synthego a375 arid1a ko synthego recombinant dna antibodies anti egfr alexa 488 biolegend - by Bioz Stars, 2026-08
86/100 stars
  Buy from Supplier

86
Cell Signaling Technology Inc primary antibodies arid1a
miR-663a is induced in esophageal cancer cells upon <t>ARID1A</t> depletion. (A) Bioinformatics analysis showed 14 differentially expressed miRs between esophageal cancer and adjacent normal tissues based on GEO datasets ( GSE157805 and GSE145198 ). (B) The protein expression of ARID1A in esophageal cancer cells transfected with shCtrl or ARID1A-targeting shRNAs was measured by Western blot analysis. GAPDH was used as the loading control. (C) Measurement of miR-663a levels in esophageal cancer cells transfected with indicated shRNAs. ***, P<0.001 vs . shCtrl. (D) The expression level of miR-663a in 50 pairs of esophageal cancer and adjacent normal tissues measured by quantitative real-time PCR analysis. (E) The correlation between the miR-663a and ARID1A mRNA expression levels in the 50 cases of esophageal cancer tissues. (F) Overall survival analysis in esophageal cancer patients according to the miR-663a expression level using the data from Kaplan-Meier plotter. Data in parentheses are 95% confidence interval. GEO, Gene Expression Omnibus; HR, hazard ratio; miR, microRNA; PCR, polymerase chain reaction; shCtrl, control shRNA; shRNA, short hairpin RNA.
Primary Antibodies Arid1a, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/arid1a+antibody/pm41639843-217-15-18?v=Cell+Signaling+Technology+Inc
Average 86 stars, based on 1 article reviews
primary antibodies arid1a - by Bioz Stars, 2026-08
86/100 stars
  Buy from Supplier

Image Search Results


miR-663a is induced in esophageal cancer cells upon ARID1A depletion. (A) Bioinformatics analysis showed 14 differentially expressed miRs between esophageal cancer and adjacent normal tissues based on GEO datasets ( GSE157805 and GSE145198 ). (B) The protein expression of ARID1A in esophageal cancer cells transfected with shCtrl or ARID1A-targeting shRNAs was measured by Western blot analysis. GAPDH was used as the loading control. (C) Measurement of miR-663a levels in esophageal cancer cells transfected with indicated shRNAs. ***, P<0.001 vs . shCtrl. (D) The expression level of miR-663a in 50 pairs of esophageal cancer and adjacent normal tissues measured by quantitative real-time PCR analysis. (E) The correlation between the miR-663a and ARID1A mRNA expression levels in the 50 cases of esophageal cancer tissues. (F) Overall survival analysis in esophageal cancer patients according to the miR-663a expression level using the data from Kaplan-Meier plotter. Data in parentheses are 95% confidence interval. GEO, Gene Expression Omnibus; HR, hazard ratio; miR, microRNA; PCR, polymerase chain reaction; shCtrl, control shRNA; shRNA, short hairpin RNA.

Journal: Translational Cancer Research

Article Title: MicroRNA-663a upregulation upon ARID1A depletion promotes the growth and migration of esophageal cancer cells by targeting FKBP8

doi: 10.21037/tcr-2025-1457

Figure Lengend Snippet: miR-663a is induced in esophageal cancer cells upon ARID1A depletion. (A) Bioinformatics analysis showed 14 differentially expressed miRs between esophageal cancer and adjacent normal tissues based on GEO datasets ( GSE157805 and GSE145198 ). (B) The protein expression of ARID1A in esophageal cancer cells transfected with shCtrl or ARID1A-targeting shRNAs was measured by Western blot analysis. GAPDH was used as the loading control. (C) Measurement of miR-663a levels in esophageal cancer cells transfected with indicated shRNAs. ***, P<0.001 vs . shCtrl. (D) The expression level of miR-663a in 50 pairs of esophageal cancer and adjacent normal tissues measured by quantitative real-time PCR analysis. (E) The correlation between the miR-663a and ARID1A mRNA expression levels in the 50 cases of esophageal cancer tissues. (F) Overall survival analysis in esophageal cancer patients according to the miR-663a expression level using the data from Kaplan-Meier plotter. Data in parentheses are 95% confidence interval. GEO, Gene Expression Omnibus; HR, hazard ratio; miR, microRNA; PCR, polymerase chain reaction; shCtrl, control shRNA; shRNA, short hairpin RNA.

Article Snippet: After blocking with 5% skimmed milk, the membranes were incubated with the primary antibodies against ARID1A (1:800; Cell Signaling Technology, Danvers, MA, USA), FKBP8 (1:800; Cell Signaling Technology), SIRT6 (1:800; Cell Signaling Technology), and GAPDH (1:5,000; Cell Signaling Technology) at 4 °C overnight.

Techniques: Expressing, Transfection, Western Blot, Control, Real-time Polymerase Chain Reaction, Gene Expression, Polymerase Chain Reaction, shRNA